Zymeworks Inc. Company Profile, Contacts & Intelligence
Zymeworks Inc. Overview
Zymeworks is a clinical-stage biotechnology company unlocking new possibilities in cancer and autoimmune disease treatment. Our mission is to make a meaningful difference in the lives of patients by advancing a growing pipeline of next-generation antibody therapeutics, including T cell engagers and antibody-drug conjugates (ADCs). Our lead asset, zanidatamab—a HER2-targeted bispecific antibody— is partnered with Jazz Pharmaceuticals and BeOne Medicines and is approved in the U.S. and China for previously-treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer. Zanidatamab is also being evaluated in multiple global clinical trials as a potential best-in-class treatment for patients with multiple HER2-expressing cancers. We’re also rapidly advancing a robust pipeline of wholly-owned ADC and multispecific programs designed to target areas of significant unmet medical need. With integrated R&D capabilities and a proven track record of scientific innovation and collaboration, we’re building strategic partnerships and a culture where passionate people can make an impact. Join us as we engineer what’s next in biotherapeutics.
- Headquarters
- Ca
- Website
- zymeworks.com
- Industry
- Biotechnology Research
- Founded
- 2003
- Stock Symbol
- OF
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Zymeworks Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Zymeworks Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Zymeworks Inc. Workforce Composition
Seniority breakdown across 41 visible profiles.
Zymeworks Inc. Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Zymeworks Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| STEMCELL Technologies | Biotechnology Research | 1.75K | View company |
| AbCellera | Biotechnology Research | 617 | View company |
| Xenon Pharmaceuticals Inc. | Biotechnology Research | 371 | View company |
| Aspect Biosystems | Biotechnology Research | 119 | View company |
| Abdera Therapeutics | Biotechnology Research | 79 | View company |
| Acuitas Therapeutics | Biotechnology | 77 | View company |
| adMare BioInnovations | Biotechnology Research | 71 | View company |
| NanoVation Therapeutics™ | Biotechnology Research | 47 | View company |
| Life Sciences BC | Biotechnology | 27 | View company |
| Notch Therapeutics | Biotechnology Research | 24 | View company |